Artigo Revisado por pares

Adjuvant recMAGE-A3 Immunotherapy After Cystectomy for Muscle-invasive Bladder Cancer: Lessons Learned from the Phase 2 MAGNOLIA Clinical Trial

2018; Elsevier BV; Volume: 5; Issue: 5 Linguagem: Inglês

10.1016/j.euf.2018.02.005

ISSN

2405-4569

Autores

Peter F.A. Mulders, Luis Martínez‐Piñeiro, Axel Heidenreich, Marko Babjuk, Marc Colombel, Renzo Colombo, Piotr Radziszewski, Igor A. Korneyev, C. Surcel, P. Yakovlev, J. Alfred Witjes, Christien Caris, Raymond G. Schipper, Wim P.J. Witjes,

Tópico(s)

Esophageal Cancer Research and Treatment

Resumo

The MAGNOLIA study, investigating the concept of perioperative immunotherapy in muscle- invasive bladder cancer, was prematurely terminated. The lessons learned that should be considered before initiating and conducting future clinical trials in this field are highlighted.

Referência(s)
Altmetric
PlumX